Cited by 895Liver Disease Diagnosis and TreatmentLiver Disease and TransplantationUltrasound Imaging and Elastography

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: a meta-analysis

Open access

Xiao, Guangqin, Zhu, Sixian, Xiao, Xiao, Yan, Lunan, Yang, Jiayin, Wu, Gang·2017·Hepatology

Open this paper in CoChat — free account Open PDF

Abstract

Many noninvasive methods for diagnosing liver fibrosis (LF) have been proposed. To determine the best method for diagnosing LF in nonalcoholic fatty liver disease (NAFLD), we conducted a systemic review and meta-analysis to compare the performance of aspartate aminotransferase to platelets ratio index (APRI), fibrosis-4 index (FIB-4), BARD score, NAFLD fibrosis score (NFS), FibroScan, shear wave elastography (SWE), and magnetic resonance elastography (MRE) for diagnosing LF in NAFLD. We compared the sensitivity, specificity, positive predictive value, negative predictive value, and area under the receiver operating characteristic curve (AUROC) of these noninvasive methods for detecting significant fibrosis (SF), advanced fibrosis (AF), and cirrhosis. Heterogeneity was explored using meta-regression. Sixty-four articles with a total of 13,046 NAFLD subjects were included. The overall mean prevalence of SF, AF, and cirrhosis was 45.0%, 24.0%, and 9.4% in NAFLD patients, respectively. With an APRI threshold of 1.0 and 1.5, the sensitivities and specificities were 50.0% and 84.0% and 18.3% and 96.1%, respectively, for AF. With a FIB-4 threshold of 2.67 and 3.25, the sensitivities and specificities were 26.6% and 96.5% and 31.8% and 96.0%, respectively, for AF. The summary sensitivities and specificities of BARD score (threshold of 2), NFS (threshold of -1.455), FibroScan M (threshold of 8.7-9), SWE, and MRE for detecting AF were 0.76 and 0.61, 0.72 and 0.70, 0.87 and 0.79, 0.90 and 0.93, and 0.84 and 0.90, respectively. The summary AUROC values using APRI, FIB-4, BARD score, NFS, FibroScan M probe, XL probe, SWE, and MRE for diagnosing AF were 0.77, 0.84, 0.76, 0.84, 0.88, 0.85, 0.95, and 0.96, respectively. CONCLUSION: MRE and SWE may have the highest diagnostic accuracy for staging fibrosis in NAFLD patients. Among the four noninvasive simple indexes, NFS and FIB-4 probably offer the best diagnostic performance for detecting AF. (Hepatology 2017;66:1486-1501).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1002/hep.29302

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection†‡
Sterling, R. K., Lissen, E., Clumeck, N., Sola, R., Correa, M. C., Montaner, J., S. Sulkowski, M., Torriani, F. J., Dieterich, D. T., Thomas, D. L., et al. (2006) · Hepatology · doi:10.1002/hep.21178 · Cited by 5,021 · cited 1×
“Dozens of noninvasive models composed of blood biochemical biomarkers have been proposed to detect LF, including aspartate aminotransferase to platelets ratio index (APRI)((5)) and fibrosis-4 index (FIB-4).((6)) However, APRI and FIB-4 were established based on patients with hepatitis C virus (HCV) infection or HIV/HC…”
Method
A Simple Noninvasive Index Can Predict Both Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis C
Wai, C.-T., Greenson, J. K., Fontana, R. J., Kalbfleisch, J. D., Marrero, J. A., Conjeevaram, H. S., & Lok, A. S.-F. (2003) · Hepatology · doi:10.1053/jhep.2003.50346 · Cited by 4,406
The NAFLD fibrosis score
Angulo, P., Hui, J. M., Marchesini, G., Bugianesi, E., George, J., Farrell, G. C., Enders, F., Saksena, S., Burt, A. D., Bida, J. P., et al. (2007) · Hepatology · doi:10.1002/hep.21496 · Cited by 3,255
Sampling Variability of Liver Fibrosis in Chronic Hepatitis C
Bédossa, P., Dargère, D., & Paradis, V. (2003) · Hepatology · doi:10.1016/j.hep.2003.09.022 · Cited by 2,370
Age as a confounding factor for the accurate non-invasive diagnosis of advanced NAFLD fibrosis
McPherson, S., Hardy, T., Dufour, J.-F., Petta, S., Romero-Gomez, M., Allison, M., Oliveira, C. P., Francque, S., Van Gaal, L., Schattenberg, J. M., et al. (2017) · American Journal of Gastroenterology · doi:10.1038/ajg.2016.453 · Cited by 945
Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease
Harrison, S. A., Oliver, D., Arnold, H. L., Gogia, S., & Neuschwander‐Tetri, B. A. (2008) · Gut · doi:10.1136/gut.2007.146019 · Cited by 869
Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography
Imajo, K., Kessoku, T., Honda, Y., Tomeno, W., Ogawa, Y., Mawatari, H., Fujita, K., Yoneda, M., Taguri, M., Hyogo, H., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.11.048 · Cited by 835
Magnetic Resonance Elastography for the Noninvasive Staging of Liver Fibrosis
Huwart, L., Sempoux, C. L., Vicaut, É., Salameh, N., Annet, L., Danse, É., Peeters, F., ter Beek, L. C., Rahier, J., Sinkus, R., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.076 · Cited by 726
Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease
Park, C. C., Nguyen, P., Hernandez, C., Bettencourt, R., Ramirez, K., Fortney, L., Hooker, J. C., Sy, E. Z., Savides, M. T., Alquiraish, M. H., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.10.026 · Cited by 715
Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
Vuppalanchi, R., & Chalasani, N. (2008) · Hepatology · doi:10.1002/hep.22603 · Cited by 568

Flagged first, then by citations

Show all 32 references

Sorted by citations

Items 601–700 of 893

Cost-Utility Analysis of Noninvasive Tests to Initiate Hepatocellular Carcinoma Surveillance in Metabolic Dysfunction-Associated Steatotic Liver Disease
Decharatanachart, P., Poovorawan, K., Tangkijvanich, P., Charatcharoenwitthaya, P., Peeraphatdit, T. B., Taychakhoonavudh, S., Treeprasertsuk, S., & Chaiteerakij, R. (2025) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000003332 · Cited by 4
Assessing the consistency of FIB-4, APRI, and GPR in evaluating significant liver fibrosis and cirrhosis in COVID-19 patients with concurrent liver diseases
Yan, P., Yu, X.-P., Chen, Z., Lan, L.-J., Kang, J., Zhao, B.-N., & Liu, D.-F. (2025) · BMC Gastroenterology · doi:10.1186/s12876-025-03770-w · Cited by 4
Automated quantification of T1 and T2 relaxation times in liver mpMRI using deep learning: a sequence-adaptive approach
Zbinden, L., Erb, S., Catucci, D., Doorenbos, L., Hulbert, L., Berzigotti, A., Brönimann, M., Ebner, L., Christe, A., Obmann, V. C., et al. (2025) · European Radiology Experimental · doi:10.1186/s41747-025-00596-9 · Cited by 4
Performance of APRI and FIB-4 Scores Compared to FibroScan: A Cross-Sectional Study in a Black Sub-Saharan African Population
Nsumbu, J. B., Makulo, J.-R., Tshiswaka, T. M., Lusunsi, C. K., & Mbendi, C. (2025) · Hepatic Medicine Evidence and Research · doi:10.2147/hmer.s533064 · Cited by 4
Use and Removal of Inferior Vena Cava Filters in Patients With Acute Brain Injury
Melmed, K. R., Chen, M. L., Al‐Kawaz, M., Kirsch, H. L., Bauerschmidt, A., & Kamel, H. (2020) · The Neurohospitalist · doi:10.1177/1941874420907531 · Cited by 4
Clinical Characteristics of a Non-Alcoholic Fatty Liver Disease Population Across the Fibrosis Spectrum Measured by Magnetic Resonance Elastography: Analysis of Screening Data
Andersen, G., Plum‐Mörschel, L., Hockings, P. D., Morsing, A., Palle, M. S., Svolgaard, O., & Flint, A. (2020) · Advances in Therapy · doi:10.1007/s12325-020-01503-x · Cited by 4
Valoración bioquímica en la enfermedad hepática grasa asociada a la disfunción metabólica
Guerra-Ruiz, A. R., Casals, G., Iruzubieta, P., Lalana, M., Leis, A., López, R. M., Crespo, J., & Morales‐Ruiz, M. (2021) · Advances in Laboratory Medicine / Avances en Medicina de Laboratorio · doi:10.1515/almed-2020-0062 · Cited by 4
Non-invasive Liver Fibrosis Scores Are Associated With Recurrence of Postoperative Chronic Subdural Hematoma
Zhang, P., Wang, H., Bao, H., Wang, N., Chen, Z., Tu, Q., Lin, X., Li, Y., Zheng, Z., Chen, Y., et al. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.873124 · Cited by 4
Expert Panel Consensus on Clinical Assertion Statements Describing Noninvasive Tools for Diagnosing Nonalcoholic Steatohepatitis
Jacobson, I. M., Wong, V. W., Castéra, L., Anstee, Q. M., Noureddin, M., Cusi, K. J., Harrison, S. A., Bugianesi, E., & Younossi, Z. M. (2022) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000001780 · Cited by 4
Feasibility and acceptability of a primary care liver fibrosis testing pathway centred on the diabetes annual review: PRELUDE1 prospective cohort study protocol
Brindley, J. H., Abeysekera, K. W. M., Hood, G., Jennings, S., Moore, J. W., Hickman, M., & Alazawi, W. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-066493 · Cited by 4
Detection of Non-Alcoholic Fatty Liver Disease with Non-invasive Tools in Turkish People Living with HIV and with Apparently Normal Liver Function
Başaran, N. Ç., İdilman, İ. S., Altunay, H., Onur, M. R., Sönmezer, M. Ç., Özışık, L., Karçaaltıncaba, M., İnkaya, A. Ç., & Ünal, S. (2023) · Current HIV Research · doi:10.2174/1570162x21666230714122716 · Cited by 4
Specific metabolic impairments indicate loss of sustained liver improvements in metabolic dysfunction-associated steatotic liver disease treatment
Luo, L., Ye, J., Zhuo, S., Ma, B., Mai, W., Cao, X., Liang, L., Wang, W. J., Feng, S., Dong, Z., et al. (2024) · HepatoBiliary Surgery and Nutrition · doi:10.21037/hbsn-23-393 · Cited by 4
Correlation Between Transient Elastography and Non-invasive Biomarker Scores for the Detection of Liver Fibrosis
Asif, M., Sohaib, M., Anwaar, W., Ahmed, A., Khalid, N. T., Tariq, H., & Jamil, M. I. (2024) · Cureus · doi:10.7759/cureus.72892 · Cited by 4
Golgi protein 73: charting new territories in diagnosing significant fibrosis in MASLD: a prospective cross-sectional study
Hong, S., Liu, Z., Li, P., Zhang, J., & Wei, H. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1506953 · Cited by 4
Screening to identify people with type 2 diabetes at risk of liver cancer in primary care: a randomised controlled trial protocol
Buchanan, R. M., Reinson, T., Bilson, J., Woodland, H., Nwoguh, C. A., Cooper, K., Harris, S., Malone, K., & Byrne, C. D. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-088043 · Cited by 4
Evaluation of liver tissue by ultrasound elastography and clinical parameters in children with multiple blood cell transfusions
Wurschi, G. W., Kentouche, K., Herrmann, K., Krumbein, I., Nold, M., Beck, J. F., Reichenbach, J. R., & Mentzel, H. (2019) · Pediatric Radiology · doi:10.1007/s00247-019-04382-9 · Cited by 4
Non-invasive Assessment of Liver Fibrosis
Redman, J. S., & Sterling, R. K. (2020) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-020-00285-z · Cited by 4
Composite BMI and Waist-to-Height Ratio Index for Risk Assessment of Non-alcoholic Fatty Liver Disease in Adult Populations
Li, N., Liu, Y., Yu, S., Hu, B., & Zhao, H. (2021) · Hepatitis Monthly · doi:10.5812/hepatmon.103607 · Cited by 4
Combining 18F-FDG PET and Gd-EOB-DTPA-enhanced MRI for staging liver fibrosis
Pan, S., Wang, L., & Xin, J. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119086 · Cited by 4
Decision Tree for the Performance of Intraoperative Liver Biopsy During Bariatric Surgery
Barbois, S., Stürm, N., Aron‐Wisnewsky, J., Clément, K., Bédossa, P., Genser, L., Hilleret, M., Costentin, C. E., Reche, F., Arvieux, C. C., et al. (2021) · Obesity Surgery · doi:10.1007/s11695-021-05309-w · Cited by 4
Nomogram for Quantitatively Estimating the Risk of Fibrosis Progression in Type 2 Diabetic Patients With Nonalcoholic Fatty Liver Disease: A Pilot Study
Xia, J., Jin, G., Hua, Q., Cui, S., & Li, J. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.917304 · Cited by 4
Clinical and Metabolic Characteristics of Hyperuricemia with Risk of Liver Fibrosis: A Cross-Sectional Study
Wang, C., Kao, H., Lai, K.-Y., Lin, C.-C., Lin, W., Liu, C.-S., & Chen, T. (2022) · Metabolites · doi:10.3390/metabo12100893 · Cited by 4
The Past, Present, and Future of Noninvasive Test in Chronic Liver Diseases
Chee, D., Ng, C. H., Chan, K. E., Huang, D. Q., Teng, M. L. P., & Muthiah, M. D. (2023) · Medical Clinics of North America · doi:10.1016/j.mcna.2022.12.001 · Cited by 4
Three‐dimensional magnetic resonance elastography in chronic liver disease
Li, C., Zhu, H., Wang, Y., Gu, Y., & Shi, Y. (2023) · Portal hypertension & cirrhosis · doi:10.1002/poh2.41 · Cited by 4
A salivary biomarker panel to detect liver cirrhosis
de Lima, L. T. F., Crawford, D. H., Broszczak, D. A., Zhang, X., Bridle, K. R., & Punyadeera, C. (2023) · iScience · doi:10.1016/j.isci.2023.107015 · Cited by 4
Non-alcoholic fatty liver disease: aspects of management of a comorbid patient. A review
Demidova, T. Y., & Омариевна, У. Ф. (2023) · Terapevticheskii arkhiv · doi:10.26442/00403660.2023.10.202435 · Cited by 4
The Relevance of Noninvasive Tools To Assess Fibrosis in Non-Alcoholic Fatty Liver Disease
Pennisi, G., Celsa, C., Giammanco, A., Spatola, F., & Petta, S. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200521133307 · Cited by 4
Are Noninvasive Methods Comparable to Liver Biopsy in Postoperative Patients After Roux-en-Y Gastric Bypass?
Pereira, P. F., von Diemen, V., Trindade, E. N., Michalczuk, M. T., Cerski, C. T. S., Mussi, A. C., Aldabe, D. F., Branchi, R. N., Knijnik, P. G., Brum, P. W., et al. (2020) · Obesity Surgery · doi:10.1007/s11695-020-04513-4 · Cited by 4
Assessment of non-alcoholic fatty liver disease by non-invasive methods: present and future perspectives
Vidal-González, D., Uribe, M., Montalvo-Jave, E. E., & Nuño‐Lámbarri, N. (2020) · Revista Médica Del Hospital General De México · doi:10.24875/hgmx.20000088 · Cited by 4
Non-invasive liver fibrosis tests in non-alcoholic fatty liver disease
Liguori, A., Zoncapè, M., & Tsochatzis, E. A. (2022) · Revista Española de Enfermedades Digestivas · doi:10.17235/reed.2022.8718/2022 · Cited by 4
Diagnosis and Staging of Metabolic Dysfunction-Associated Steatotic Liver Disease Using Biomarker-Directed Aptamer Panels
Kjær, M. B., Jørgensen, A. G., Fjelstrup, S., Dupont, D. M., Bus, C., Eriksen, P. L., Thomsen, K. L., Risikesan, J., Nielsen, S., Wernberg, C. W., et al. (2025) · Biomolecules · doi:10.3390/biom15020255 · Cited by 3
Diagnostic and Prognostic Performance of the Agile 3+ Score in Patients With Chronic Hepatitis B and Concurrent MASLD After Complete Viral Suppression With Nucleos(t)ide Analogues
Yu, H., Wu, J., Li, M., Hu, C., Ren, Y., Jiang, H., Huang, Y., Lei, Y., Chen, J., Wu, B., et al. (2025) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.70099 · Cited by 3
Lean Metabolic Dysfunction‐Associated Steatotic Liver Disease: A Wolf in Sheep's Clothing
Fang, X., Xu, C., Lu, J., Zhuang, R., Xu, X. X., & Wei, X. (2025) · Cell Biochemistry and Function · doi:10.1002/cbf.70136 · Cited by 3
Initial Aspartate Aminotransferase-to-platelet Ratio Index is Associated with Sepsis-associated Liver Dysfunction in Adult Patients with Sepsis: A Retrospective Cohort Study
Zhang, B., Li, X., Qin, Z., Dong, D., & Yu, W. (2025) · Indian Journal of Critical Care Medicine · doi:10.5005/jp-journals-10071-25079 · Cited by 3
Imaging in MASLD
Venkatesh, S. K. (2026) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2026.2636184 · Cited by 3
Diagnosing and defining MASLD in people living with chronic hepatitis B
Martyn, E. M., Arenas‐Pinto, A., Gilson, R. J. C., Chandiwana, N. C., Flanagan, S., MacDonald, D. C., Tsochatzis, E. A., Venter, W. D., Manne‐Goehler, J., & Matthews, P. C. (2026) · Communications Medicine · doi:10.1038/s43856-026-01383-2 · Cited by 3
Fc receptor-like 5 gene polymorphisms and mRNA expression are associated with liver fibrosis in chronic hepatitis B
Yang, J., Gu, J., Wang, H., Shi, J., Lu, L., She, W., & Wang, Y. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.988464 · Cited by 3
Interplay of metabolic dysfunction-associated fatty liver disease and papillary thyroid carcinoma: insights from a Chinese cohort
Xiao, R., Wang, Q., Ni, C., Pan, W. X., Wu, W., Cai, Y., Xie, K., & You, J. (2024) · Journal of Endocrinological Investigation · doi:10.1007/s40618-024-02391-6 · Cited by 3
The steatosis‐associated fibrosis estimator score is a useful indicator of recurrence and survival after initial curative hepatectomy for hepatocellular carcinoma
Bekki, T., Ohira, M., Imaoka, Y., Hattori, M., Nakano, R., Sakai, H., Kuroda, S., Tahara, H., Ide, K., Kobayashi, T., et al. (2024) · Annals of Gastroenterological Surgery · doi:10.1002/ags3.12846 · Cited by 3
Liver Fibrosis and Perihematomal Edema Growth in Primary Intracerebral Hemorrhage
Parikh, N. S., Jesudian, A. B., Kamel, H., Hanley, D. F., Ziai, W., Murthy, S. B., Hanley, D. F., Butcher, K., Davis, S. M., GREGSON, B. A., et al. (2020) · Neurocritical Care · doi:10.1007/s12028-020-01081-4 · Cited by 3
Risk Stratification for Hepatocellular Carcinoma in Patients with Non-alcoholic Fatty Liver Disease
Truong, E., Han, C., Muthiah, M. D., & Noureddin, M. (2023) · Current Hepatology Reports · doi:10.1007/s11901-023-00595-7 · Cited by 3
Potential of electronic devices for detection of health problems in older adults at home: A systematic review and meta-analysis
Cao, Y., Zhao, X., Yang, Y., Zhu, S., Zheng, L.-D., Ying, T., Sha, Z., Zhu, R., & Wu, T. (2023) · Geriatric Nursing · doi:10.1016/j.gerinurse.2023.02.007 · Cited by 3
Technical Acoustic Measurements Combined with Clinical Parameters for the Differential Diagnosis of Nonalcoholic Steatohepatitis
Zhao, Y., Qiu, C., Dong, Y., Wang, X., Chen, J., Yao, J., Jiang, Y., Zhang, C., Weng, H., Liu, Y., et al. (2023) · Diagnostics · doi:10.3390/diagnostics13091547 · Cited by 3
Effect of Neo-Policaptil Gel Retard on Liver Fat Content and Fibrosis in Adults with Metabolic Syndrome and Type 2 Diabetes: A Non-invasive Approach to MAFLD
Guarino, G., Strollo, F., Corte, T. D., Satta, E., & Gentile, S. (2023) · Diabetes Therapy · doi:10.1007/s13300-023-01478-2 · Cited by 3
Shear wave elastography as a non-invasive tool for staging liver fibrosis in children: A study in Algerian pediatric patients
Bicha, S., Boumaraf, H., & Lakehal, A. (2023) · Indian Journal of Gastroenterology · doi:10.1007/s12664-023-01464-3 · Cited by 3
Alcohol-related cancer morbidity and mortality are stratified using modified albumin platelet product
Fujita, K., Morishita, A., Oura, K., Ono, M., Himoto, T., & Masaki, T. (2024) · Scientific Reports · doi:10.1038/s41598-023-50778-x · Cited by 3
The adverse characteristics of hepatocellular carcinoma in the non‐cirrhotic liver disproportionately disadvantage Black patients
Shaltiel, T., Sarpel, U., & Branch, A. D. (2024) · Cancer Medicine · doi:10.1002/cam4.6654 · Cited by 3
FIB‐4 index is associated with mortality in critically ill patients with alcohol use disorder: Analysis from the MIMIC‐IV database
Pan, Y., Xia, Y., Zhang, X., Cai, X., Pan, J., & Dong, Y. (2024) · Addiction Biology · doi:10.1111/adb.13361 · Cited by 3
Advanced liver fibrosis is associated with decreased gait speed in older patients with chronic liver disease
Fudeyasu, K., Ushio, K., Nomura, T., Kawae, T., Iwaki, D., Nakashima, Y., Nagao, A., Hiramatsu, A., Murakami, E., Oka, S., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-57342-1 · Cited by 3
The Use of Non-invasive Biomarkers to Screen for Advanced Fibrosis Associated with Metabolic Dysfunction-associated Steatotic Liver Disease in People with Type 2 Diabetes: A Narrative Review
Williams, D. M., Nagaraj, J., Stephens, J. W., & Min, T. (2025) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2025.21.1.4 · Cited by 3
Does NAFLD Fibrosis Score predict mortality risk among MAFLD patients?: a systematic review and meta-analysis
Rahadini, A. A. D., & Rahadina, A. (2021) · Bali Medical Journal · doi:10.15562/bmj.v10i2.2359 · Cited by 3
Intra-individual comparison of liver stiffness measurements by magnetic resonance elastography and two-dimensional shear-wave elastography in 888 patients
Ichikawa, H., Yasuda, E., Kumada, T., Takeshima, K., Ogawa, S., Tsunekawa, A., Goto, T., Nakaya, K., Akita, T., & Tanaka, J. (2022) · ULTRASONOGRAPHY · doi:10.14366/usg.22052 · Cited by 3
Association of dietary inflammatory potential and non-alcoholic fatty liver disease in US adults
Tian, H., Qu, H., Zheng, Y., Sun, Y.-Y., Wang, W.-J., & Wu, Y.-L. (2023) · European Journal of Gastroenterology and Hepathology · doi:10.1097/meg.0000000000002609 · Cited by 2
Noninvasive diagnosis of liver fibrosis in NAFLD: Tips tricks
Zuberbuhler, F., & Boursier, J. (2019) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2019.03.009 · Cited by 3
Cardiovascular and metabolic complications of childhood obesity
Malíková, J. K., Čepová, J., Doušová, T., Durilová, M., Konopásek, P., Šumnı́k, Z., & Lebl, J. (2024) · Česko-slovenská pediatrie · doi:10.55095/cspediatrie2024/007 · Cited by 2
Alterations of hepatic lipid content following COVID-19 in persons with type 2 diabetes
Kupriyanova, Y., Yurchenko, I., Bobrov, P., Bartels, F., Wierichs, S., Jonuscheit, M., Korzekwa, B., Prystupa, K., Schön, M., Mendez, D., et al. (2025) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2024-004727 · Cited by 2
Prognostic significance of the liver stiffness value on magnetic resonance imaging elastography in patients undergoing hepatectomy for hepatocellular carcinoma
Chiba, H., Sato, N., Ozeki, A., Sugawara, R., Azuma, T., Tsukida, S., Muto, M., Haga, J., Kofunato, Y., Ishigame, T., et al. (2025) · Surgery Today · doi:10.1007/s00595-025-03034-w · Cited by 2
Comparative mortality outcomes in metabolic dysfunction-associated steatotic liver disease and nonalcoholic fatty liver disease subtypes in the United States
Zhang, P., Yang, S., Hu, R., Peng, T., Yu, P., Zeng, Y., Ye, C., Wang, P., Dong, X., & Che, Z. (2025) · PLoS ONE · doi:10.1371/journal.pone.0335230 · Cited by 2
Prevalence of Hepatic Fibrosis and Performance of Non-invasive Liver Fibrosis Scores in an Eastern Indian Diabetic Population with NAFLD
Sanyal, D., Chowdhury, S., Goswami, S., Dasgupta, A., Chowdhury, A. S., Mondal, S., Bhattacharyya, S., Chaudhuri, S. R., & Sikdar, M. (2025) · Journal of the ASEAN Federation of Endocrine Societies · doi:10.15605/jafes.040.02.16 · Cited by 2
MicroRNA and Protein Biomarkers of Intestinal Permeability in the Assessment of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Białek, D., Wunsch, E., Kempińska‐Podhorodecka, A., Abramczyk, J., Wunsch, A., & Kozłowska, K. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262311351 · Cited by 2
Sequential Fibrosis-4 Index and Mac-2 Binding Protein Glycosylation Isomer Combination Improve Detection of Advanced Fibrosis in Metabolic Dysfunction–Associated Steatotic Liver Disease: A Multicenter Study
Morishita, A., Kamada, Y., Sumida, Y., Arai, T., Takahashi, H., Seko, Y., Toyoda, H., Hayashi, H., Yamaguchi, K., Iwaki, M., et al. (2026) · Gastro Hep Advances · doi:10.1016/j.gastha.2026.100901 · Cited by 2
A metabolite-augmented FIB-4 machine learning panel achieves superior liver fibrosis staging in chronic liver disease
Chen, Y.-Y., Yang, T.-B., Chen, T.-L., Xiao, H.-M., Zhou, K.-J., Ding, K.-K., Liu, Q., Li, M.-C., Peng, X., Sun, T., et al. (2026) · Cell Reports Medicine · doi:10.1016/j.xcrm.2026.102726 · Cited by 2
Advances in quantitative ultrasound for metabolic dysfunction-associated steatotic liver disease diagnosis
Ma, Z., Liu, B., Zhou, S., Yang, S., Sun, X., Jiang, X., & Sun, X. (2026) · Frontiers in Physiology · doi:10.3389/fphys.2026.1802284 · Cited by 2
Role of serum hyaluronic acid in predicting necroinflammatory activity of the nonalcoholic fatty liver disease
Güveli, H., & Kurdaş, O. Ö. (2022) · Hepatology forum/Hepatology forum (Online) · doi:10.14744/hf.2022.2022.0004 · Cited by 2
Estimation of liver fibrosis using elastrography in chelestatic diseases: systematic review and meta-analysis
Carrasco, N. M., Jerez, A. L., Garrido, E., & González, M. G. (2023) · Revista Española de Enfermedades Digestivas · doi:10.17235/reed.2023.9254/2022 · Cited by 3
Are endosonographic shear wave measurement results reliable without interquartile range median value?
Albayrak, F., & Dursun, H. (2024) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2024.01.006 · Cited by 2
Obesity-Related Ciliopathies: Focus on Advances of Biomarkers
Zhang, Q., Huang, Y., Gao, S., Ding, Y., Zhang, H., Chang, G., & Wang, X. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25158484 · Cited by 2
Non-invasive diagnosis of metabolic dysfunction associated steatotic liver disease (MASLD)
Tseng, M., Syed, T., & Siddiqui, M. S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-26710-9.00004-3 · Cited by 2
Roles of olive oil and physical exercise in non-alcoholic fatty liver disease after ultrasound-based evaluation
Zhu, W. (2025) · World Journal of Hepatology · doi:10.4254/wjh.v17.i2.100243 · Cited by 2
Construction of a community-based primary screening and hospital-based confirmatory screening pathway in pediatric nonalcoholic fatty liver disease
Yao, M., Xing, Y.-F., Liu, S.-H., Peng, Y., Yang, S.-H., Chen, J., Zhao, J., & Wang, H. (2025) · World Journal of Gastroenterology · doi:10.3748/wjg.v31.i28.108321 · Cited by 2
Non-Invasive Testing in Metabolic Dysfunction Associated Fatty Liver Disease
Gofton, C., & George, J. (2025) · Archives of Medical Research · doi:10.1016/j.arcmed.2025.103337 · Cited by 2
The Role of an Elevated Fibrosis‐4 Index in Neurocognitive Decline and Brain Volume Reduction in Older Adults With Metabolic Dysfunction‐Associated Steatotic Liver Disease
Nagaoka, M., Nagaoka, K., Kajitani, N., Yoshiura, K., Yoshimaru, Y., Watanabe, T., Setoyama, H., Fujise, N., Takebayashi, M., & Tanaka, Y. (2025) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.70218 · Cited by 2
Biochemical Biomarkers of NAFLD/NASH
Celsa, C., Pennisi, G., Spatola, F., Giannetti, A., & Petta, S. (2020) · Springer eBooks · doi:10.1007/978-3-030-37173-9_6 · Cited by 2
Liver Magnetic Resonance Elastography: Clinical Use and Interpretation
Guo, J., Sack, I., & Garcia, S. R. M. (2020) · Springer eBooks · doi:10.1007/978-3-030-40542-7_6 · Cited by 2
Fibrosis Assessment in Patients with NAFLD
de Lédinghen, V. (2020) · Springer eBooks · doi:10.1007/978-3-030-40542-7_10 · Cited by 2
Nonalcoholic Fatty Liver Disease and Liver Fibrosis in Bariatric Patients: Tehran Obesity Treatment Study (TOTS)
Barzin, M., Motamedi, M. A. K., Khalaj, A., Serahati, S., Khalili, D., Morakabati, A., Valizadeh, M., Azizi, F., Hosseinpanah, F., & Rakhshani, N. (2018) · Hepatitis Monthly · doi:10.5812/hepatmon.64380 · Cited by 2
Risk Factors for Non-alcoholic Fatty Liver Disease in Chinese Population: A Five-year Follow-up Study
Zhao, H., & Hu, B. (2019) · Iranian Red Crescent Medical Journal · doi:10.5812/ircmj.91064 · Cited by 2
HBV infection may reduce the risk of metachronous liver metastasis in postoperative pathological stage 2 colorectal cancer
Jiaming, Z., Pin-zhu, H., Xiaoyan, G., Shuyun, T., Lin, R., Huanmiao, Z., Wu, X., Xiao, Y., Mingzhe, H., Yu, H., et al. (2020) · International Journal of Colorectal Disease · doi:10.1007/s00384-020-03712-w · Cited by 2
Computer-assisted ultrasound quantification analysis in fatty liver model of rats
Lou, Z., Wang, C., Li, Q., & Li, Y. (2020) · Annals of Palliative Medicine · doi:10.21037/apm-19-545 · Cited by 2
Clinical predictive score for detecting nonalcoholic fatty liver disease with significant fibrosis in patients with metabolic syndrome
Kositamongkol, C., Charernboon, T., Chaisathaphol, T., Washirasaksiri, C., Auesomwang, C., Sitasuwan, T., Charatcharoenwitthaya, P., & Phisalprapa, P. (2021) · Medicine · doi:10.1097/md.0000000000027640 · Cited by 2
Non-invasive diagnosis of liver fibrosis associated with nonalcoholic steatohepatitis
Garbuzenko, D. V. (2021) · Russian Journal of Evidence-Based Gastroenterology · doi:10.17116/dokgastro20211004175 · Cited by 2
MRI in liver cirrhosis
Alzoubi, O., Arar, A., Singh, V., Ertürk, Ş. M., Mózes, F. E., & Pavlides, M. (2022) · Portal hypertension & cirrhosis · doi:10.1002/poh2.6 · Cited by 2
Fibrosis assessment in patients with nonalcoholic fatty liver disease: Adherence to proposed algorithms and barriers to complying with them
Marciano, S., Dirchwolf, M., Torres, M. C., Allevato, J. A., Dans, C. G., García, B., Pollarsky, F. D., Gaite, L., Sirotinsky, E., Velit-Rios, B., et al. (2021) · Revista de Gastroenterología de México (English Edition) · doi:10.1016/j.rgmxen.2021.09.002 · Cited by 2
Clinical Model for the Prediction of Severe Liver Fibrosis in Adult Patients with Type II Diabetes Mellitus
Calapod, O., Marin, A. M., Stoian, A. P., & Fierbinteanu-Braticevici, C. G. (2022) · Diagnostics · doi:10.3390/diagnostics12081829 · Cited by 2
From NAFLD to Chronic Liver Diseases. Assessment of Liver Fibrosis through Non-Invasive Methods before Liver Transplantation: Can We Rely on Them?
Auricchio, P., & Finotti, M. (2023) · Transplantology · doi:10.3390/transplantology4020008 · Cited by 2
Role of patatin-like phospholipase domain-containing 3 gene for decreasing kidney function in recently diagnosed diabetes mellitus
Zaharia, O., Straßburger, K., Knebel, B., Binsch, C., Kupriyanova, Y., Möser, C., Bódis, K. B., Prystupa, K., Yurchenko, I., Cardenas, D. M. M., et al. (2024) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2024.103137 · Cited by 2
Gd-EOB-DTPA DCE-MRI biomarkers in a rabbit model of liver fibrosis.
Ji, Y., Zhang, C., Huang, Z., Wang, X., Yue, L., Gao, M., Hu, H., Su, Q.-J., Han, Y., Liu, B., et al. (2018) · Europe PMC (PubMed Central) · Cited by 2
Comment on: ‘Monitoring for methotrexate‐induced liver fibrosis in many UK dermatology centres is out of date and needs reform’
Patel, N. P. (2022) · Clinical and Experimental Dermatology · doi:10.1111/ced.15253 · Cited by 2
It’s time for a unified North American guideline on the use of ultrasound and MRI in patients with MASLD
Wilson, M. P., Fung, C. I., & Low, G. (2024) · Abdominal Radiology · doi:10.1007/s00261-024-04406-5 · Cited by 2
Evaluation of liver parenchyma with shear wave elastography in patients with rheumatoid arthritis receiving disease‐modifying antirheumatic drug therapy
Tezcan, D., Özer, H., Topaloğlu, Ö. F., Hakbilen, S., Durmaz, M. S., Yılmaz, S., & Ozturk, M. H. (2024) · Journal of Clinical Ultrasound · doi:10.1002/jcu.23847 · Cited by 1
Impact of non-alcoholic fatty liver disease and liver fibrosis on outcomes of acute ischemic stroke: A systematic review and meta-analysis
Yang, L., Han, J., Qin, C., & Song, F. (2025) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.41.2.10729 · Cited by 1
Prevalence, Risk Factors, and Clinical Outcomes with Advanced HIV Disease Among People with Newly Diagnosed HIV During the “Treat-All” Era: A Retrospective Cohort Study From Xi’an City, China
Jin, J., Pan, S., Chen, J., Yin, J., Ba, H., Hou, H., Zhang, Y., & Ma, K. (2025) · Infection and Drug Resistance · doi:10.2147/idr.s518809 · Cited by 1
Prediction of Advanced Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease by Type IV Collagen 7S
Ishiba, H., Sumida, Y., Kamada, Y., Fujii, H., Iwaki, M., Hayashi, H., Toyoda, H., Oeda, S., Hyogo, H., Kawanaka, M., et al. (2025) · Gastro Hep Advances · doi:10.1016/j.gastha.2025.100668 · Cited by 1
Non-alcoholic fatty liver disease as a link in the cardiometabolic continuum: Focus on hypertriglyceridemia
Demidova, T. Y., Расуловна, Б. А., & Омариевна, У. Ф. (2025) · FOCUS Endocrinology · doi:10.62751/2713-0177-2025-6-2-09 · Cited by 1
The Fibrosis‐4 score is associated with overall mortality and severe haematological toxicity in older patients with cancer: Analysis of two prospective cohort studies
de Salins, V., Martinez‐Tapia, C., Gay, P., Morel, A., Bringuier, M., Boudou, P., Corsin, L., Aregui, A., Canovas, J., Rautou, P., et al. (2025) · International Journal of Cancer · doi:10.1002/ijc.70071 · Cited by 1
Plasma sphingolipids predict advanced liver fibrosis development in patients with type 2 diabetes
Béland‐Bonenfant, S., Denimal, D., de Barros, J.-P. P., Choubley, H., Rouland, A., Simoneau, I., Duvillard, L., Aho, S., Bouillet, B., Petit, J., et al. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70156 · Cited by 1
Higher risk of postpartum phase transition to immune-active among HBeAg-positive pregnant women with indeterminate phase
Tang, Q., Wang, C., Li, H., Chen, Z., Liu, X.-Q., Xue, Y., Qiu, Y., Cai, N., Zeng, Y., & Hu, P. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1652690 · Cited by 1
Pre‐ to Post‐Pandemic Increases in Excessive Alcohol Use, Binge Drinking, and Associated Liver Fibrosis Among U.S. Adults
Kim, D. S., Goyal, R. M., Ayoub, W. S., Kuo, A., Trivedi, H. D., Vipani, A., Wang, Y., Yang, J. D., Liangpunsakul, S., & Kim, H.-S. (2026) · Liver international communications. · doi:10.1002/lci2.70032 · Cited by 1
Determinants of abnormal liver-related biomarkers in adult COVID-19 patients
ZHANG, S., Hu, Y., Liu, L., Ning, X., Li, Q., & Xiao, G. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1662585 · Cited by 1
Diagnostic value of non-invasive indices for assessing liver fibrosis in Chinese children with metabolic dysfunction-associated steatotic liver disease
Zhou, J., Liu, M., Qiu, J. L., Ouyang, W., Zhu, G., Chen, W., Li, S., & Zhao, H. (2026) · Frontiers in Pediatrics · doi:10.3389/fped.2025.1694863 · Cited by 1

Authors: Xiao, G., Zhu, S., Xiao, X., Yan, L., Yang, J., & Wu, G.
Affiliations: Huazhong University of Science and Technology (CN)
Tongji Hospital (CN)
Henan Medical University (CN)
Department of Liver Surgery,West China Hospital of Sichuan University,Chengdu,China
West China Hospital of Sichuan University (CN)
Corresponding author: Wu, Gang
ORCID: Xiao, Xiao
Yang, Jiayin
Wu, Gang
Venue: Hepatology
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2017-09-26
Volume: 66
Issue: 5
Pages: 1486-1501
ISSN: 0270-9139 (ISSN-L)
1527-3350
DOI: 10.1002/hep.29302
OpenAlex: W2622132351
Cited by: 895
References: 32
Citations by year: 2026: 68 · 2025: 85 · 2024: 109 · 2023: 118 · 2022: 142 · 2021: 147 · 2020: 117 · 2019: 62 · 2018: 38 · 2017: 7
FWCI: 47.96
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor)
doi.wiley.com/10.1002/tdm_license_1.1 (tdm)
Locations: Hepatology (publishedVersion)
PubMed (publishedVersion)
Funders: National Natural Science Foundation of China (81600482, 81472201, 81172150)
Topics: Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Ultrasound Imaging and Elastography
Keywords: non-alcoholic fatty liver disease, liver fibrosis, noninvasive fibrosis assessment, APRI, FIB-4, NAFLD fibrosis score, BARD score, FibroScan, shear wave elastography, magnetic resonance elastography, liver cirrhosis, diagnostic accuracy, sensitivity and specificity, ultrasound elastography, liver stiffness, meta-regression
MeSH terms: China, Fibrosis, Humans, Liver, Liver Cirrhosis, Ultrasonography, Prevalence, Elasticity Imaging Techniques, Non-alcoholic Fatty Liver Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: a meta-analysis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks